WGU D027 Study Guide||QUESTIONS
AND CORRECT ANSWERS||GRADED
A+||LATEST UPDATE||DOWNLOAD
NOW||
Autosomal Dominant -CORRECT ANSWER 1 parent has, 50% change of child having
Autosomal Recessive -CORRECT ANSWER Both parents are carriers, 25% change of
child having, 50% chance child is a carrier.
Cystic Fibrosis -CORRECT ANSWER affects pancreas causing secretions in lungs
21st Trisomy -CORRECT ANSWER Down Syndrome
Klinefelter Syndrome (XXY) -CORRECT ANSWER male has extra X, female like
qualities
Turner Syndrome -CORRECT ANSWER Missing X in females
Alpha Thalassemia -CORRECT ANSWER inherited blood disorder; mild to severe
anemia
Beta Thallasemia -CORRECT ANSWER low hemoglobin; contraindicated medication
ferrous sulfate
Prevalence Risk -CORRECT ANSWER proportion of the population affected at a
certain time
Incidence rate -CORRECT ANSWER number of new cases divided by population
Innate immunity -CORRECT ANSWER inflammation; increased vascular permeability
B&T lymphocytes -CORRECT ANSWER immune response
primary malignant tumor -CORRECT ANSWER lack of organization of cells
glucocorticoids -CORRECT ANSWER used in combination with other agent to treat
lymphoid tissue (leukemia). glucocorticoids are directly toxic to lymphoid tissues.
, Selective estrogen receptor modulators (SERM) -CORRECT ANSWER for hormone
receptor positive and advanced breast cancer. (Tamoxifin reduces risk and recurrence
risk)
Heart failure -CORRECT ANSWER impairment of the ventricle to fill with or eject blood;
heart cannot meet metabolic need of the body.
CHF -CORRECT ANSWER heart cannot keep up with metabolic needs; volume
overload in pulmonary area
Left Ventricular Dysfunction -CORRECT ANSWER reduced ejection fraction; ventricle
having issue ejecting blood.
normal ejection fraction -CORRECT ANSWER 55 - 60 % (blood pumped out with each
heartbeat)
Ejection fraction of 50% - reduced or preserved? -CORRECT ANSWER preserved
Diastolic CHF -CORRECT ANSWER preserved ejection fraction, problem is with filling
Systolic CHF -CORRECT ANSWER reduced ejection fraction, problem is with ejecting
Left sided CHF -CORRECT ANSWER pulmonary (JVD, fluid volume overload, rails, S-3
murmurs) ** #1 cause of Right sided CHF
BNP -CORRECT ANSWER gold standard lab test to diagnose CHF
Echocardiogram -CORRECT ANSWER Diagnostic tool, evaluates heart structure and
function
At Risk for HF - Stage A -CORRECT ANSWER no structural heart disease or
symptoms of heart failure
Stage A HF co-morbidities -CORRECT ANSWER htn, atherosclerotic disease,
diabetes, metabolic syndrome, patients using cardiotoxins with family history
Therapy goals of stage A HF -CORRECT ANSWER treat htn, encourage smoking
cessation, encourage regular exercise, treat lipid disorders, discourage alcohol
intake/drug use, control metabolic syndrome
Meds: ACEI or Angiotensin II RB for vascular disease or diabetes (avapro, losartan,
benicar, diovan, etc)
At Risk for HF - Stage B -CORRECT ANSWER structural heart disease but no
symptoms of heart failure
AND CORRECT ANSWERS||GRADED
A+||LATEST UPDATE||DOWNLOAD
NOW||
Autosomal Dominant -CORRECT ANSWER 1 parent has, 50% change of child having
Autosomal Recessive -CORRECT ANSWER Both parents are carriers, 25% change of
child having, 50% chance child is a carrier.
Cystic Fibrosis -CORRECT ANSWER affects pancreas causing secretions in lungs
21st Trisomy -CORRECT ANSWER Down Syndrome
Klinefelter Syndrome (XXY) -CORRECT ANSWER male has extra X, female like
qualities
Turner Syndrome -CORRECT ANSWER Missing X in females
Alpha Thalassemia -CORRECT ANSWER inherited blood disorder; mild to severe
anemia
Beta Thallasemia -CORRECT ANSWER low hemoglobin; contraindicated medication
ferrous sulfate
Prevalence Risk -CORRECT ANSWER proportion of the population affected at a
certain time
Incidence rate -CORRECT ANSWER number of new cases divided by population
Innate immunity -CORRECT ANSWER inflammation; increased vascular permeability
B&T lymphocytes -CORRECT ANSWER immune response
primary malignant tumor -CORRECT ANSWER lack of organization of cells
glucocorticoids -CORRECT ANSWER used in combination with other agent to treat
lymphoid tissue (leukemia). glucocorticoids are directly toxic to lymphoid tissues.
, Selective estrogen receptor modulators (SERM) -CORRECT ANSWER for hormone
receptor positive and advanced breast cancer. (Tamoxifin reduces risk and recurrence
risk)
Heart failure -CORRECT ANSWER impairment of the ventricle to fill with or eject blood;
heart cannot meet metabolic need of the body.
CHF -CORRECT ANSWER heart cannot keep up with metabolic needs; volume
overload in pulmonary area
Left Ventricular Dysfunction -CORRECT ANSWER reduced ejection fraction; ventricle
having issue ejecting blood.
normal ejection fraction -CORRECT ANSWER 55 - 60 % (blood pumped out with each
heartbeat)
Ejection fraction of 50% - reduced or preserved? -CORRECT ANSWER preserved
Diastolic CHF -CORRECT ANSWER preserved ejection fraction, problem is with filling
Systolic CHF -CORRECT ANSWER reduced ejection fraction, problem is with ejecting
Left sided CHF -CORRECT ANSWER pulmonary (JVD, fluid volume overload, rails, S-3
murmurs) ** #1 cause of Right sided CHF
BNP -CORRECT ANSWER gold standard lab test to diagnose CHF
Echocardiogram -CORRECT ANSWER Diagnostic tool, evaluates heart structure and
function
At Risk for HF - Stage A -CORRECT ANSWER no structural heart disease or
symptoms of heart failure
Stage A HF co-morbidities -CORRECT ANSWER htn, atherosclerotic disease,
diabetes, metabolic syndrome, patients using cardiotoxins with family history
Therapy goals of stage A HF -CORRECT ANSWER treat htn, encourage smoking
cessation, encourage regular exercise, treat lipid disorders, discourage alcohol
intake/drug use, control metabolic syndrome
Meds: ACEI or Angiotensin II RB for vascular disease or diabetes (avapro, losartan,
benicar, diovan, etc)
At Risk for HF - Stage B -CORRECT ANSWER structural heart disease but no
symptoms of heart failure
